Yeah would have to read up on it, my formal science is decades old. I do get the impression that the apoptosis and local + systemic clearance provides confidence of reduced negative affects vis a vis uncontrolled pluripotent growth subsequent to anti inflammatory effects mediated through downstream cell changes.
Maybe that will be part of a future in vitro potency assay matrix but demonstrated in vitro trilineage pluripotency is seldom manifest in vivo from what I've learnt at the Sandstone University of Youtube etc.
Maybe NP + disc volume positive effects is just mediated via ECM augmentation in an intercellular modulatory mechanism - nice to imagine a future in vivo chondrogenesis role with a robust correlated in vitro potency assay for MSB product though.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-18281
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.838B |
Open | High | Low | Value | Volume |
$1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 59183 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9437 | 1.655 |
1 | 5193 | 1.635 |
2 | 91323 | 1.620 |
5 | 7972 | 1.615 |
2 | 105419 | 1.610 |
Price($) | Vol. | No. |
---|---|---|
1.480 | 14712 | 2 |
1.485 | 27935 | 7 |
1.500 | 5000 | 1 |
1.520 | 1000 | 1 |
1.525 | 15998 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online